Skip to main content

How drugs work

Prescription Drugs Special Report

Ever wonder how the medications you take act in your body? This brief guide explains how several classes of popular drugs work.

Thousands of medications are in use today. Here are some of the most common mechanisms by which these drugs achieve their effects:

Antibiotic Drugs -- The development of safe and effective drugs to cure infections was arguably the most significant advance in drug development of the 20th century. Perhaps the most famous example is penicillin, which is derived from a toxin produced by the fungus Penicillium notatum that contaminated a laboratory experiment. The Scottish scientist Alexander Fleming noticed that the Penicillium fungus had done something to kill the bacterium Staphylococcus, which is responsible for many human infections.

Antibiotics have several modes of action. Penicillin disrupts the cell walls of bacteria, causing them to die. Some other antibiotics interfere with the ability of microorganisms to manufacture essential proteins or to reproduce.

Replacement-Therapy Drugs -- Some drugs work by replacing a substance the body lacks. For example, an iron supplement can correct iron deficiency, and daily insulin injections can treat diabetes. Another common example of a replacement-therapy drugs is a synthetic form of natural thyroid hormone (levothyroxine) that remedies the effects of a thyroid gland that has stopped working or was removed because of disease.

Drugs That Act on Enzymes -- Many body processes involve enzymes, which are proteins that facilitate biochemical reactions. An enzyme might, for example, bind to a molecule and break it down into smaller pieces, as occurs during digestion. Or an enzyme might build a larger molecule by joining small molecular building blocks.

Modulating the undesirable action of enzymes can correct disease processes. In fact, the top-selling drugs in the world, the cholesterol-lowering "statin" drugs, inhibit the action of a liver enzyme called HMG-CoA reductase. HMG-CoA reductase performs a key step in the biochemical assembly line that manufactures cholesterol. By blocking this enzyme, statin drugs foil the process, reducing blood levels of cholesterol -- particularly LDL, the "bad" cholesterol that raises the risk of heart disease.


Drugs That Act on Cell Receptors -- Cell receptors are structures on the surfaces of body cells. They are often compared to locks. The "key" that fits into the lock (a protein or some other molecule) is called a ligand. When the ligand binds to the surface of the receptor, forming a chemical bond, it signals the machinery inside the cell to do something.

For example, insulin binds to cell receptors and allows sugar (glucose) in the blood to enter cells. Some new drugs, such as the osteoporosis drug raloxifene (Evista), actually alter the shape of a receptor in ways that modify its action. Evista binds to the estrogen receptor, helping to prevent the bone loss associated with reduced estrogen.

Receptor-Blocking Drugs --
Sometimes known as antagonists, these drugs prevent the natural ligand "keys" from entering the cell receptor "locks," much as two people can't occupy the same seat in musical chairs.

In beta-blockers, an important class of cardiac drugs, the active ingredient is a molecule that prevents the hormone noradrenaline from binding to receptors in the heart. Blocking these "beta1" receptors slows the contractions of the heart muscle and makes them less forceful, which leads to reduced demand on the heart muscle and also lowers blood pressure.

Drugs That Alter Cell Transport --
There are still other ways to interfere with the transfer of molecular messages.

For example, the antidepressant drug fluoxetine (Prozac) is a selective serotonin reuptake inhibitor (SSRI). This drug works by preventing (or inhibiting) brain cells from collecting (or "re-uptaking") and subsequently processing for recycling used molecules of the brain messenger chemical known as serotonin. Thus, Prozac has the effect of increasing the amount of this messenger molecule available to brain cells, which helps to alleviate the symptoms of depression for many people.

Reblog this post [with Zemanta]

Comments

Popular posts from this blog

Indian government outlines policies on drug pricing to favor poorer patients, and increase clinical trials

The Indian government is looking to review the existing drug price control measures in order to make medicines more affordable in the country, and at increasing the number of clinical trials taking place in the country, reports The Pharma Letter's India correspondent. In a parallel move, the Health Ministry is also preparing a framework for public private partnership to tackle the menace of non-communicable diseases in the country, In a move that could potentially result in affordable Medicare and health security moving to a larger section of the population, the government is considering a rash of policy measures in favor of poor patients. Talks are also on in government circles to abolish clinical trials on proven drugs that have been approved and marketed for at least two years in the European Union, United States, UK, Australia, Canada and Japan. A draft proposal in this regard has been prepared by the Health Ministry. If instituted, it would reduce the time taken to introduce n...

The polypill: Medicine's magic bullet

The capsule costs pennies, contains a simple cocktail of medicines, and halves the number of strokes and heart attacks. Doctors want to hand it out in the first mass medication for the middle-aged in Britain. So why are the big drug companies so uninterested? The magic bullet, containing five medicines in a single capsule, sharply reduced cholesterol and blood pressure levels and has the potential to "halve cardiovascular events in average middle-aged individuals", the researchers say. The finding is a major boost for a medication with huge potential against the worldwide epidemic of heart disease and stroke. Doctors say that, if further trials prove successful, all men aged over 50 and women aged over 60 should be offered the pill in what would be the first example of mass medication for the middle-aged in Britain. Yet no Western pharmaceutical company has shown interest in developing the so-called polypill because it does not promise big profits. It would sell for pennies b...

Delay in 'Made in India' chikungunya vaccine, researchers seek government intervention

India offers a rare ray of hope for an indigenously-made vaccine against chikungunya, but delay in finding volunteers is impeding its development.   With chikungunya spreading very fast in the country, researchers are seeking urgent government intervention for speedy completion of the vital clinical trials.  Chikungunya is a dreaded infection transmitted through the bite of the mosquito. There is no known cure and till date, there is no vaccine anywhere in the world again ..  The novel vaccine candidate against chikungunya crossed a big hurdle last year when Bharat Biotech, a Hyderabad-based vaccine pioneer, got permission to start human trials and the first human subjects received the vaccine a few months ago.  The company says the phase-I trials will "evaluate the vaccine's safety, tolerability and immunogenicity. The placebo controlled study involving 60 healthy volunteers would test escalating doses of the vaccine in prime-boost regimen".  Continue reading here:  Sour...